We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Oxford Immunotec Pitches in on Valneva’s Early-Stage COVID Vaccine Trial
Oxford Immunotec Pitches in on Valneva’s Early-Stage COVID Vaccine Trial
Oxford Immunotec is teaming up with Valneva to help the French biotech with a phase 1/2 UK trial of its inactivated COVID-19 vaccine candidate, VLA2001.